Amal M.  Johnson net worth and biography

Amal Johnson Biography and Net Worth

Director of Intuitive Surgical
Amal M. Johnson has been a member of our Board of Directors since April 2010. From March 2012 to December 2017, Ms. Johnson was a member of the Board of Directors of Author-it Software Corporation (“Author-it”), a Software as a Service (“SaaS”) private company that provides a platform for creating, maintaining, and distributing single-sourced technical content, and Executive Chairman from March 2012 to October 2016.

Prior to joining Author-it, Johnson led MarketTools, Inc., a SaaS company, as Chief Executive Officer from 2005 to 2008, and then as Chairman of the Board of Directors until the company was acquired in January 2012.

She has served as a member of the Board of Directors of Essex Property Trust, Inc. since February 2018, CalAmp since December 2013, and Mellanox Technologies, Ltd. from October 2006 through April 2020.

Johnson came to the United States as a foreign student from the Middle East and attended Montclair State University where she earned a B.A. in Mathematics. She also studied Computer Science at the Stevens Institute of Technology, Graduate School of Engineering.

What is Amal M. Johnson's net worth?

The estimated net worth of Amal M. Johnson is at least $4.60 million as of November 16th, 2023. Ms. Johnson owns 11,706 shares of Intuitive Surgical stock worth more than $4,596,010 as of March 18th. This net worth approximation does not reflect any other investments that Ms. Johnson may own. Learn More about Amal M. Johnson's net worth.

How do I contact Amal M. Johnson?

The corporate mailing address for Ms. Johnson and other Intuitive Surgical executives is 1020 KIFER ROAD, SUNNYVALE CA, 94086. Intuitive Surgical can also be reached via phone at (408) 523-2100 and via email at [email protected]. Learn More on Amal M. Johnson's contact information.

Has Amal M. Johnson been buying or selling shares of Intuitive Surgical?

Amal M. Johnson has not been actively trading shares of Intuitive Surgical during the past quarter. Most recently, Amal M. Johnson sold 9,567 shares of the business's stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $300.00, for a transaction totalling $2,870,100.00. Following the completion of the sale, the director now directly owns 11,706 shares of the company's stock, valued at $3,511,800. Learn More on Amal M. Johnson's trading history.

Who are Intuitive Surgical's active insiders?

Intuitive Surgical's insider roster includes Craig Barratt (Director), Myriam Curet (EVP), Myriam Curet (EVP), Robert DeSantis (EVP), Gary Guthart (CEO), Amal Johnson (Director), Amy Ladd (Director), Keith Leonard (Director), Alan Levy (Director), Marshall Mohr (CFO), Kara Reiter (SVP), David Rosa (EVP), Mark Rubash (Director), Jamie Samath (SVP), and Fredrik Widman (VP). Learn More on Intuitive Surgical's active insiders.

Are insiders buying or selling shares of Intuitive Surgical?

During the last year, insiders at the medical equipment provider sold shares 36 times. They sold a total of 438,718 shares worth more than $153,622,264.86. The most recent insider tranaction occured on March, 15th when VP Fredrik Widman sold 5,041 shares worth more than $2,001,629.87. Insiders at Intuitive Surgical own 0.9% of the company. Learn More about insider trades at Intuitive Surgical.

Information on this page was last updated on 3/15/2024.

Amal M. Johnson Insider Trading History at Intuitive Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/16/2023Sell9,567$300.00$2,870,100.0011,706View SEC Filing Icon  
11/8/2022Sell6,375$239.36$1,525,920.0011,224View SEC Filing Icon  
9/8/2022Sell6,375$210.76$1,343,595.0011,224View SEC Filing Icon  
8/3/2022Sell6,375$238.04$1,517,505.0011,224View SEC Filing Icon  
11/24/2021Sell7,500$333.73$2,502,975.00View SEC Filing Icon  
5/12/2021Sell2,500$817.82$2,044,550.006,223View SEC Filing Icon  
5/20/2020Sell3,000$550.00$1,650,000.0012,468View SEC Filing Icon  
10/23/2018Sell1,000$500.00$500,000.009,874View SEC Filing Icon  
5/31/2017Sell1,000$917.27$917,270.003,787View SEC Filing Icon  
3/15/2017Sell1,000$750.00$750,000.003,460View SEC Filing Icon  
4/25/2016Sell2,500$640.00$1,600,000.004,960View SEC Filing Icon  
See Full Table

Amal M. Johnson Buying and Selling Activity at Intuitive Surgical

This chart shows Amal M Johnson's buying and selling at Intuitive Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intuitive Surgical Company Overview

Intuitive Surgical logo
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $392.62
Low: $390.79
High: $401.27

50 Day Range

MA: $380.18
Low: $330.56
High: $400.59

2 Week Range

Now: $392.62
Low: $237.58
High: $403.00

Volume

1,653,977 shs

Average Volume

1,734,510 shs

Market Capitalization

$139.16 billion

P/E Ratio

78.06

Dividend Yield

N/A

Beta

1.36